Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

8.25USD
8:39pm IST
Change (% chg)

$0.18 (+2.23%)
Prev Close
$8.07
Open
$8.02
Day's High
$8.36
Day's Low
$8.02
Volume
7,163
Avg. Vol
50,584
52-wk High
$12.00
52-wk Low
$3.75

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.43 December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 2.63 5.50 0.00 0.00
Quarter Ending Mar-19 3 0.50 1.50 0.00 --
Year Ending Dec-18 2 5.09 6.30 3.89 1.95
Year Ending Dec-19 5 3.23 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Dec-18 3 -0.43 -0.37 -0.52 -0.51
Quarter Ending Mar-19 3 -0.61 -0.43 -0.88 --
Year Ending Dec-18 3 -1.95 -1.86 -2.02 -2.13
Year Ending Dec-19 5 -2.33 -1.48 -3.51 -2.59

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 1.08 0.00 1.08 100.00
Quarter Ending Jun-18 1.63 2.38 0.74 45.50
Quarter Ending Mar-18 1.60 1.51 0.09 5.63
Quarter Ending Dec-17 1.16 1.48 0.32 27.34
Quarter Ending Sep-17 1.09 1.26 0.17 15.95
Earnings (per share)
Quarter Ending Sep-18 -0.45 -0.54 0.09 -21.08
Quarter Ending Jun-18 -0.38 -0.46 0.08 -22.34
Quarter Ending Mar-18 -0.44 -0.49 0.05 -12.00
Quarter Ending Dec-17 -0.53 -0.38 0.15 -27.76
Quarter Ending Sep-17 -0.55 -0.48 0.07 -12.73

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2.63 1.52 0.98 0.98 0.00
Quarter Ending Mar-19 0.50 0.75 0.75 0.75 --
Year Ending Dec-18 5.09 4.89 5.29 5.29 1.95
Year Ending Dec-19 3.23 3.15 2.63 2.63 6.01
Earnings (per share)
Quarter Ending Dec-18 -0.43 -0.37 -0.41 -0.41 -0.51
Quarter Ending Mar-19 -0.61 -0.64 -0.64 -0.64 --
Year Ending Dec-18 -1.95 -1.82 -1.80 -1.80 -2.13
Year Ending Dec-19 -2.33 -2.38 -2.29 -2.29 -2.59

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 1 0 2 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 1 0 1
Year Ending Dec-19 1 0 1 0
Earnings
Quarter Ending Dec-18 0 0 3 0
Quarter Ending Mar-19 2 0 2 0
Year Ending Dec-18 0 0 0 3
Year Ending Dec-19 1 0 1 1